As a follow-up to our podcast on the Ranbaxy Scandal, we are joined by medicinal chemist John Tucker, PhD and hypertension specialist Swapnil Hiremath, MD. Our distinguished guests share with us their perspectives and impressions on the unsettling question of generic drugs.